Post-effective amendment to a registration statement that is not immediately effective upon filing

Restatement of Previously Issued Financial Statements (Tables)

v3.22.2.2
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
P3 Health Partners Inc.    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Summary of the effects of the restatement on each financial statement line item affected by the restatement as of the dates, and for the periods

The following tables summarize the restatement adjustments on each financial statement line item affected by the restatement as of the dates, and for the periods, indicated:

    

As Previously

    

Network

    

Preferred Returns

    

Class A Units

    

Revenue

    

    

Reported

    

Adjustments

    

Adjustments

    

Adjustments

    

Adjustment

    

As Restated

Condensed Consolidated Statement of Operations for the Six Months Ended June 30, 2021 (Unaudited)

 

  

 

  

 

  

 

  

 

  

 

  

Capitated Revenue

$

294,860,130

$

$

$

$

(4,335,073)

$

290,525,057

Other Patient Service Revenue

 

8,122,849

 

 

 

 

(2,763,520)

 

5,359,329

Total Operating Revenue

 

302,982,979

 

 

 

 

(7,098,593)

 

295,884,386

Medical Expenses

 

297,570,662

 

 

 

 

(565,640)

 

297,005,022

Total Operating Expenses

 

335,409,517

 

 

 

 

(565,640)

 

334,843,877

Operating Loss

 

(32,426,538)

 

 

 

 

(6,532,953)

 

(38,959,491)

Interest Expense, net

 

(8,487,374)

 

 

3,993,325

 

 

 

(4,494,049)

Total Other Expenses

 

(19,148,953)

 

 

3,993,325

 

 

 

(15,155,628)

Net Loss Attributable to Non-Controlling Interests

 

(5,241,713)

 

5,241,713

 

 

 

 

Net Loss (formerly Net Loss Attributable to Controlling Interests)

 

(46,333,778)

 

(5,241,713)

 

3,993,325

 

 

(6,532,953)

 

(54,115,119)

Condensed Consolidated Statement of Operations for the Three Months Ended June 30, 2021 (Unaudited)

 

  

 

  

 

  

 

  

 

  

 

  

Capitated Revenue

$

147,159,665

$

$

$

$

(5,598,799)

$

141,560,866

Other Patient Service Revenue

 

4,258,933

 

 

 

 

(1,233,356)

 

3,025,577

Total Operating Revenue

 

151,418,598

 

 

 

 

(6,832,155)

 

144,586,443

Medical Expenses

 

150,679,717

 

 

 

 

(299,200)

 

150,380,517

Total Operating Expenses

 

170,856,707

 

 

 

 

(299,200)

 

170,557,507

Operating Loss

 

(19,438,108)

 

 

 

 

(6,532,955)

 

(25,971,063)

Interest Expense, net

 

(4,406,240)

 

 

2,036,476

 

 

 

(2,369,764)

Total Other Expenses

 

(5,529,823)

 

 

2,036,476

 

 

 

(3,493,347)

Net Loss Attributable to Non-Controlling Interests

 

(1,959,421)

 

1,959,421

 

 

 

 

Net Loss (formerly Net Loss Attributable to Controlling Interests)

 

(23,008,510)

 

(1,959,421)

 

2,036,476

 

 

(6,532,955)

 

(29,464,410)

Condensed Consolidated Statement of Changes in Members' Deficit for the Six Months Ended June 30, 2021

 

  

 

  

 

  

 

  

 

  

 

  

Preferred Return at 8% for Class A Units

$

1,817,564

$

$

(1,817,564)

$

$

$

Net Loss

 

(51,575,491)

 

 

3,993,325

 

 

(6,532,953)

 

(54,115,119)

Balance as of June 30,2021

 

(146,395,455)

 

 

6,743,106

 

(43,656,170)

 

 

(183,308,519)

Condensed Consolidated Statement of Changes in Members' Deficit for the Three Months Ended June 30, 2021

 

  

 

  

 

  

 

  

 

  

 

  

Preferred Return at 8% for Class A Units

$

926,852

$

$

(926,852)

$

$

$

Net Loss

 

(24,967,931)

 

 

2,036,476

 

 

(6,532,955)

 

(29,464,410)

Balance as of June 30,2021

 

(146,395,455)

 

 

6,743,106

 

(43,656,170)

 

 

(183,308,519)

Condensed Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2021

 

  

 

  

 

  

 

  

 

  

 

  

Net Loss

$

(51,575,491)

$

$

3,993,325

$

$

(6,532,953)

$

(54,115,119)

Health Plan Settlements Receivable/Premiums Receivable

 

(5,320,861)

 

 

 

 

6,532,953

 

1,212,092

Class A and Class D Preferred Returns

 

3,993,325

 

 

(3,993,325)

 

 

 

Condensed Consolidated Statements of Changes in Members' Deficit for the 3 Months Ended March 31, 2021

 

  

 

  

 

  

 

  

 

  

 

  

Preferred Return at 8% for Class A Units

$

890,612

$

$

(890,612)

$

$

$

Net Loss

 

(26,607,560)

 

 

1,956,848

 

 

 

(24,650,712)

Balance as of March 31,2021

 

(122,918,168)

 

 

5,633,581

 

(43,656,269)

 

6,532,954

 

(154,407,902)

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2020

 

  

 

  

 

  

 

  

 

  

 

  

Balance as of December 31, 2020

$

(97,661,735)

$

$

4,567,346

$

(43,656,270)

$

6,532,954

$

(130,217,705)

*Rounding may cause variances

    

As Previously

Network

Preferred Returns

Class A Units

Revenue

    

Reported

    

Adjustments

    

Adjustments

    

Adjustments

    

Adjustments

    

As Restated

Consolidated Balance Sheet as of December 31, 2020

Health Plan Settlement Receivable

$

38,429,833

$

$

$

$

6,532,954

$

44,962,787

Total Current Assets

84,347,633

6,532,954

90,880,587

Total Assets

99,902,252

6,532,954

106,435,206

Class A Units Subject to Possible Redemption

43,656,270

43,656,270

Class D Units Subject to Possible Redemption

51,608,900

(4,567,346)

47,041,554

Contributed Capital

41,764,270

(41,764,270)

Class A Preferred Returns

3,815,034

(3,815,034)

Accumulated Equity-Based Compensation

1,368,567

(921,092)

447,475

Retained Loss from Non-Controlling Interests

 

(18,187,381)

 

18,187,381

 

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

(126,242,225)

(18,187,381)

8,382,381

(970,908)

6,532,954

(130,485,179)

Total Member’s Deficit

(97,661,735)

4,567,346

(43,656,270)

6,532,954

(130,217,705)

Total Liabilities, Mezzanine Equity & Members' Equity (Deficit)

99,902,252

6,532,954

106,435,206

Consolidated Statement of Operations for the Year Ended December 31, 2020

 

  

 

Capitated Revenue

$

471,551,241

$

$

$

$

9,188,336

$

480,739,577

Other Patient Service Revenue

13,990,050

(3,666,102)

10,323,948

Total Operating Revenue

485,541,291

5,522,234

491,063,525

Medical Expenses

485,513,143

(1,010,720)

484,502,423

Total Operating Expenses

520,661,923

(1,010,720)

519,651,203

Operating Loss

(35,120,632)

6,532,954

(28,587,678)

Interest Expense, net

(9,970,260)

7,437,080

(2,533,180)

Total Other Income (Expense)

(10,260,944)

7,437,080

(2,823,864)

Net Loss Attributable to Non-Controlling Interests

(4,307,071)

4,307,071

Net Loss (formerly Net Loss Attributable to Controlling Interests)

 

(41,074,505)

 

(4,307,071)

7,437,080

6,532,954

 

(31,411,542)

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2020

Preferred Return(s) at 8% (Class A + Class D Units)

$

7,437,080

$

$

(7,437,080)

$

$

$

Net Loss

(45,381,576)

7,437,080

6,532,954

(31,411,542)

Balance as of December 31, 2020

(97,661,735)

4,567,346

(43,656,270)

6,532,954

(130,217,705)

Consolidated Statements of Cash Flows for the Year Ended December 31 2020

Net Loss

$

(45,381,576)

$

$

7,437,080

$

$

6,532,954

$

(31,411,542)

Health Plan Settlements Receivable/Premiums Receivable

(20,974,286)

(6,532,954)

(27,507,240)

Class A and Class D Preferred Returns

7,437,080

(7,437,080)

Consolidated Balance Sheet as of December 31, 2019

 

  

 

 

Class A Units Subject to Possible Redemption

$

$

$

$

43,656,270

$

$

43,656,270

Class D Units Subject to Possible Redemption

47,556,622

(515,068)

47,041,554

Contributed Capital

41,764,270

(41,764,270)

Class A Preferred Returns

430,230

(430,230)

Accumulated Equity-Based Compensation

921,092

(921,092)

Retained Loss from Non-Controlling Interests

 

(13,880,310)

 

13,880,310

 

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

(85,167,716)

(13,880,310)

945,297

(970,908)

(99,073,637)

Total Member’s Deficit

(55,932,434)

515,068

(43,656,271)

(99,073,637)

Consolidated Statement of Operations for the Year Ended December 31, 2019

 

  

 

 

Capitated Revenue

$

138,727,943

$

$

$

$

604,764

$

139,332,707

Other Patient Service Revenue

7,166,889

(1,017,484)

6,149,405

Total Operating Revenue

145,894,832

(412,720)

145,482,112

Medical Expenses

141,442,457

(412,720)

141,029,737

Total Operating Expenses

185,430,503

(412,720)

185,017,783

Interest Expense, net

(3,479,139)

945,297

$

(2,533,842)

Total Other Income (Expense)

(3,381,184)

945,297

(2,435,887)

Net Loss Attributable to Non-Controlling Interests

(7,907,592)

7,907,592

Net Loss (formerly Net Loss Attributable to Controlling Interests)

 

(35,009,263)

 

(7,907,592)

945,297

 

(41,971,558)

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2019

Preferred Return(s) at 8% (Class A + Class D Units)

$

945,298

$

$

(945,298)

$

$

$

Net Loss

(42,916,855)

945,297

(41,971,558)

Conversion of Debt to Class A Units

3,764,025

(3,764,025)

Class A Units Issued

11,184,468

(11,184,468)

Redemption of Class A Units

(15,000,000)

15,000,000

Modification of Class A

(1,892,002)

(1,892,002)

Balance as of December 31, 2019

(55,932,434)

515,068

(43,656,271)

(99,073,637)

Consolidated Statements of Cash Flows for the Year Ended December 31 2019

Net Loss

$

(42,916,855)

$

$

945,297

$

$

$

(41,971,558)

Class A and Class D Preferred Returns

945,297

(945,297)

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2018

Balance as of December 31, 2018

$

(13,868,589)

$

$

$

(41,815,530)

$

$

(55,684,119)